Joost Peerbooms

136 Chapter 8 66. Giusti I, D’Ascenzo S, Guido Macchiarelli G, et al. In vitro evidence supporting applications of platelet derivatives in regenerative medicine Blood Transfus. 2020; 18: 117-29. 67. Giusti I, Rughetti A, D’Ascenzo S, et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009; 49(4): 771-78. 68. Coombes B, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010; 376(9754): 1751-67. 69. Smidt N, van der Windt D, Assendelft W, et al. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet. 2002; 359: 657–62. 70. Coombes B, Bisset L, Brooks P, et al. Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: a randomized controlled trial. JAMA. 2013; 309: 461–69. 71. Filardo G, Kon E. PRP: product rich in placebo. Knee Surg Sports Traumatol Arthrosc. 2016; 24 :3702–03. 72. Doherty M, Dieppe P. The “placebo” response in osteo- arthritis and its implications for clinical practice. Osteoarthritis Cartilage. 2009; 17(10): 1255–62. 73. Nesello P, Baroni A, Da Silva Selistre L. Level of Evidence and Industry Sponsorship Associated with Favorable Outcomes in Publications on Platelet-Rich-Plasma Therapy in Musculoskeletal Disorders. Rev Bras Ortop. 2020; 55(3): 263–68. 74. Leung A, Luu S, Regehr G et al. “First do not harm”: Balancing competing priorities in surgical practice. Acad Med. 2012; 87: 1368-74. 75. Fitzpatrick J, Bulsara M, Zheng M. The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy. A Meta-analysis of Randomized Controlled Clinical Trials. Am J Sports Med. 2017, 45(1): 226-33.